RFG Advisory LLC Has $1.52 Million Stake in Aflac Incorporated (NYSE:AFL)

RFG Advisory LLC reduced its position in shares of Aflac Incorporated (NYSE:AFL) by 4.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,377 shares of the financial services provider’s stock after selling 783 shares during the period. RFG Advisory LLC’s holdings in Aflac were worth $1,516,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Fortitude Family Office LLC acquired a new stake in Aflac in the 4th quarter valued at $25,000. CoreFirst Bank & Trust acquired a new stake in shares of Aflac in the fourth quarter valued at about $25,000. Studio Investment Management LLC bought a new stake in Aflac during the fourth quarter worth about $27,000. Bruce G. Allen Investments LLC acquired a new position in Aflac during the fourth quarter valued at approximately $32,000. Finally, Impact Partnership Wealth LLC grew its stake in Aflac by 471.4% in the third quarter. Impact Partnership Wealth LLC now owns 400 shares of the financial services provider’s stock valued at $31,000 after purchasing an additional 330 shares in the last quarter. 67.44% of the stock is currently owned by institutional investors.

Aflac Price Performance

Aflac stock opened at $83.16 on Wednesday. The company has a market capitalization of $47.85 billion, a price-to-earnings ratio of 10.73, a PEG ratio of 2.33 and a beta of 0.91. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.33. Aflac Incorporated has a 12 month low of $64.06 and a 12 month high of $86.26. The stock’s 50 day moving average is $81.77 and its 200-day moving average is $81.34.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.25 earnings per share for the quarter, missing the consensus estimate of $1.47 by ($0.22). The firm had revenue of $3.78 billion for the quarter, compared to the consensus estimate of $4.44 billion. Aflac had a return on equity of 17.59% and a net margin of 24.92%. During the same quarter in the previous year, the business earned $1.29 EPS. Equities research analysts expect that Aflac Incorporated will post 6.43 EPS for the current year.

Analysts Set New Price Targets

AFL has been the topic of a number of analyst reports. Piper Sandler upped their price objective on Aflac from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Friday, April 5th. The Goldman Sachs Group increased their price target on shares of Aflac from $61.00 to $75.00 and gave the company a “sell” rating in a research note on Tuesday, January 9th. StockNews.com upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research note on Thursday, March 28th. Evercore ISI downgraded shares of Aflac from an “in-line” rating to an “underperform” rating and raised their target price for the company from $76.00 to $78.00 in a research note on Thursday, January 4th. Finally, UBS Group lifted their price target on Aflac from $80.00 to $84.00 and gave the stock a “neutral” rating in a report on Wednesday, January 10th. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $81.58.

Insiders Place Their Bets

In other news, Director Arthur Reginald Collins sold 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $79.73, for a total transaction of $239,190.00. Following the transaction, the director now directly owns 5,592 shares of the company’s stock, valued at $445,850.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Arthur Reginald Collins sold 3,000 shares of the stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $79.73, for a total transaction of $239,190.00. Following the sale, the director now directly owns 5,592 shares of the company’s stock, valued at approximately $445,850.16. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Masatoshi Koide sold 30,493 shares of the business’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $79.91, for a total value of $2,436,695.63. Following the completion of the transaction, the director now directly owns 86,090 shares of the company’s stock, valued at approximately $6,879,451.90. The disclosure for this sale can be found here. Insiders sold 46,493 shares of company stock worth $3,765,706 in the last quarter. 0.80% of the stock is currently owned by corporate insiders.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.